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Abstract
Insertion of green fluorescent protein (GFP) encoding-gene into virus genes has provided a 
valuable tool for flavivirus research. This study aimed to develop dengue virus (DENV) replicons 
expressing GFP reporter that would provide a fast in vitro system to analyze functional roles of 
specific DENV sequences in viral replication. Two classes of recombinant replicon constructs 
were generated; one was a RNA-launched replicon with a GFP gene directly inserted into a full-
length DENV genome (FL-DENV/GFP), and the other consisted of 4 types of DNA-launched 
DENV subgenomic replicons with GFP replacement at various structural genes (Δ-DENV/GFP). 
The FL-DENV/GFP resulted in GFP expression in transfected cells with no viable DENV being 
recovered from the transfection. The Δ-DENV/GFP constructs with partial structural gene deletion 
(ΔC-, ΔCprM/M-, ΔprM/M-, or ΔE-) expressed bright and long lasting GFP. The GFP expression 
intensity in living cells correlated well with the level of RNA replication. Various mutations in the 
5′noncoding region of DENV-2 previously shown to be important genetic determinants for virus 
replication and mouse virulence were incorporated into the 5 different replicon constructs. 
Characterizations of 29 mutants demonstrated that these replicons can provide a useful platform 
for a quick and powerful in vitro system to analyze genetic determinants of DENV replication. 
These constructs can also be useful for development of vectors expressing foreign genes for 
various researches.
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Dengue virus (DENV) is a positive strand RNA virus in the Flaviviridae family. This virus 
family member includes yellow fever virus (YFV), Japanese encephalitis virus (JEV), West 
Nile virus (WNV), and tick-borne encephalitis virus (TBEV). DENV is transmitted to 
humans by infected mosquitoes and causes diseases, ranging from mild, self-limiting dengue 
fever, to severe dengue hemorrhagic fever, and dengue shock syndrome. The global 
distribution of DENV results in more than 50 million cases of infection, and an estimated 
2.5 billion people are at risk each year (Gubler, 2002). Based on distinct antigenic 
characteristics, DENVs are divided into four serotypes; DENV-1, -2, -3 and -4. Re-infection 
with a second serotype virus increases the risk of developing the more severe dengue 
hemorrhagic fever/shock syndrome due to induction of antibody-dependent enhancement of 
the infection and/or T-cell mediated immunopathogenesis (Halstead et al., 1984; Rothman 
and Ennis, 1999). Although recent advances in DENV vaccine development puts several 
potential candidates on pre-clinical and clinical trials, there is currently no DENV vaccine 
yet available, partly due to lack of understanding of viral and cellular factors during the viral 
infection.
The positive-strand RNA genome of DENV is organized into 5′ noncoding region (5′NCR)-
capsid protein (C)-pre membrane/membrane (prM/M)-envelope protein (E)-non-structural 
proteins 1–5 (NS1-NS2A-NS2B-NS3-NS4A-NS4B-NS5)-3′NCR. The C protein is essential 
in encapsidation of the viral genome. prM/M protein serves as a chaperon for E protein 
during protein processing in cells and is involved in maturation of the virions. The mature 
viral envelope contains the M and E transmembrane proteins. The E protein is responsible 
for cell receptor binding, induction of the major neutralizing antibody response, mediation 
of virus-specific membrane fusion in acid pH endosomes, and virus assembly in cells. The 
NS proteins are involved in host cellular immune response, helicase and protease enzyme 
activity, and viral RNA-dependent RNA replication. As with the other positive strand RNA 
viruses, the 5′NCR and 3′NCR of DENV are predicted to form secondary RNA structures 
and cyclization which interact with cellular and viral proteins for viral protein translation 
(Ali and Siddiqui, 1995) and RNA genome replication (Guesdon et al., 2001; Kuhn et al., 
2002). Sequences of 5′NCR together with capsid protein gene and 3′NCR are required to 
structurally interact during virus replication (Alvarez et al., 2005; You et al., 2001). The 
functional significance of dengue 5′NCR is demonstrated by the restricted growth of 
DENV-4 deletion mutants (Cahour et al., 1995), attenuation effect of the DENV-2 PDK-53 
vaccine candidate (Butrapet et al., 2000), and reduced virus replication of DENV-2 5′NCR 
mutants (Leardkamolkarn et al., 2010; Sirigulpanit et al., 2007).
Accumulating data from DENV studies at the molecular level are the basis for dengue 
vaccine development and anti-DENV drug design. Reporter genes, such as green fluorescent 
protein (GFP) and luciferase tagged to viruses have been used to study flavivirus biology. 
Most previous studies reported constructs with parts of the viral structural gene region 
removed resulting in replicon plasmids that can be replicated in cells. For example, 
subgenomic WNV replicon expressing reporter gene was developed to promote antiviral 
drug screening (Lo et al., 2003a; Rossi et al., 2005; Shi et al., 2002). DENV-2 New Guinea 
C replicons containing GFP or luciferase reporter stabilized in BHK-21 cells were 
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established for antiviral screening and siRNA testing (Ng et al., 2007). DENV-2 16681 
replicon containing luciferase reporter was created and used to study 3′NCR structure and an 
anti-viral compound targeting the 3′NCR (Alvarez et al., 2005; Holden et al., 2006). In this 
study, we reported various strategies in constructing DENV-2 replicons with GFP reporter 
that provided a convenient and fast system to investigate the effects of 5′NCR mutations in 
viral replication. We also compared 4 types of subgenomic DENV/GFP constructs to 
identify an optimal replicon expressing the GFP.
2. Materials and methods
2.1. Cells and DENV-2 cDNA plasmid
Vero cells (African green monkey kidney cells) and BHK-21 cells (baby hamster kidney 
cells), were cultured in Eagles minimum essential medium with Earle’s balanced salts 
(MEM/EBSS; HyClone®, Thermo Scientific, USA) containing 10% fetal bovine serum 
(FBS, Hyclone, USA), 100 U/ml penicillin and 100 µg/ml streptomycin at 37 °C in a 5% 
CO2 incubator. The plasmid, D2/IC-30P-A (Fig. 1A) (Kinney et al., 1997), containing full-
length DENV-2 cDNA derived from wild type (wt) strain 16681, and its subclones 
containing different parts of DENV-2 cDNA were used for construction of the clones in this 
study. The pD2/IC-30P-A was also used to derive wt virus for this study.
2.2. Construction of a full-length dengue virus plasmid expressing GFP fusion protein 
(pFL-DENV/GFP)
Aequorea coerulescens green fluorescent protein (GFP) gene was amplified from pAcGFP1-
N1 (Clontech, USA) by polymerase chain reaction (PCR) using forward (AcGFP-N1-F2: 
ACAGATGATCATTATGGTGAGCAAGGGCGCCGAGC) and reverse (AcGFP-BclI-
R:GGCTGATCATCTTGTACAGCTCATCCATGCCGTGG) primers containing natural 
BclI restriction site (bold) and extra bases of the DENV-2 (underlined) to ensure in frame 
cloning of the GFP gene. Plasmid containing wt DENV-2 cDNA nt 1–1380 (Kinney et al., 
1997) was used for insertion of the GFP fragment at the BclI site (DEN-2 cDNA nt-407 
position). The DENV-2/GFP fusion fragment of the subclone was then cloned into the full-
length DEN-2 cDNA clone, pD2/IC-30P-A by SstI and SphI restriction sites. The final FL-
DENV/GFP (FL for “full-length”) plasmid containing the GFP gene inserted in the nt 407 
position, which is located within the signal sequence (SS) between the capsid and prM genes 
(Fig. 1B) was confirmed by restriction enzyme analysis, PCR, and sequencing.
2.3. Construction of subgenomic DENV-2 replicon with GFP reporter gene (Δ-DENV/GFP)
Four different types of subgenomic DENV-2 replicons (ΔC, ΔCprM/M, ΔprM/M, and ΔE) 
with reporter GFP were made by replacing part of the DENV-2 structural gene region with 
the GFP gene (Fig. 1C–F). A foot-and-mouth-disease virus 2A protease (FMDV-2A) 
cleavage factor was included in the constructs at the 3′end of GFP to ensure C-terminal 
cleavage of the GFP. The GFP with FMDV-2A fragment was directly PCR amplified from 
pAcGFP1 plasmid (Clontech, USA) using pairs of forward and reverse primers as follows: 
SalI-AcGFP-F (5′TATAATGTCGACTATGGTGAGCAAGGGC GCCGAGC3′) and 
FMDV2-BclI-R (5′ATATGATCATGGGCCCGGGGTTGGACTCGACGTCT3′) for ΔC-
DENV/GFP; SalI-AcGFP-F and FMDV2-BoxI-R 
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(5′TATAATTGGCCATGATGGTGACCAAGGGCGCCGAG3′) and FMDV2-BoxI-R for 
ΔprM/MDENV/GFP; and SphI-AcGFP-F 
(5′TATAATGCATGCAATGGTGAGCAAGGGCGCCGAGC3′) and FMDV2-BamHI-R 
(5′ATATATATAGGATCCGGGCCCGGGGTTGGACTCGACGTCT3′) for ΔE-DENV/
GFP. Underlined letters are the DENV-2 nucleotide sequences before and after GFP gene to 
ensure in frame cloning, bold letters indicate the natural restriction sites in the DENV-2 
clone used for cloning. The resulting Δ-DENV/GFP plasmids have the following partial 
DENV-2 structural gene deletions: partial C gene (nt 172–405) deletion in ΔC construct, 
partial C-prM/M (nt 172–909) deletion in the ΔCprM/M construct, partial prM/M deletion 
(nt 556–909) deletion in ΔprM/M plasmid, and partial E deletion (nt 1386–2203) in the ΔE 
construct.
The original full length pD2/IC-30PA clone contains the T7 promoter, and required in vitro 
transcription to derive viral RNA prior to mammalian cell transfection. In the Δ-DENV/GFP 
constructs, the original T7 promoter on the plasmid was replaced with a human 
cytomegalovirus immediate early (CMV-IE) promoter which allowed direct RNA 
transcription in the plasmid-transfected mammalian cells. The CMV-IE sequence was also 
amplified from pAcGFP1-N1 (Clontech, USA) and cloned upstream to the 5′-end of 
DENV-2 gene in each replicon plasmid.
2.4. Cell transfection of FL-DENV/GFP RNA or Δ-DENV/GFP plasmid
To derive RNA transcripts from the FL-DENV/GFP plasmid with T7 promoter, 200 ng of 
linearized plasmid was in vitro transcribed using m7GpppA cap analog (New England 
Biolabs, USA) and reagents from Ribomax™ Large Scale RNA Production system T7 
(Promega, USA). Then, total volume of in vitro transcribed RNA was transfected into 4 × 
106 BHK-21 or Vero cells using the Bio-Rad Genepulse electroporator (BioRad, USA). Two 
pulses of 1.5 kV, 25 µF and infinite ohms were applied to BHK-21 cells (in a 0.2 cm gene 
pulser cuvette) and one pulse of 225 V with 25 ms of pulse length was applied to Vero cells 
(in a 0.4 cm gene pulser cuvette).
For Δ-DENV/GFP plasmids containing CMV-IE promoter, 1 × 106 BHK-21 cells were 
transfected (285 V, 1100 µF, 500 ohms, 2 mm cuvette, 1 pulse) with 8 µg of the plasmid. 
The transfected cells were cultured in MEM containing 10% FBS and penicillin/
streptomycin.
2.5. Analysis of viral protein expression and GFP expression
Viral protein expression in the FL-DENV/GFP RNA transfected cells was determined by 
immunofluorescence assay (IFA) at 24 and 48 h post transfection (pt), using mouse 
hyperimmune ascetic fluid polyclonal antibodies against DENV-2 New Guinea C strain and 
anti-mouse-IgG antibody conjugated with FITC. The cells were counterstained with Evan’s 
blue and were observed under the fluorescence microscope. The transfected cells were also 
observed for GFP expression in the living cells by periodical examination directly under an 
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inverted fluorescence microscope (Olympus, USA). When intracellular GFP expression was 
observed, the transfected cells were harvested, fixed, and counterstained with DAPI.
The cells transfected with Δ-DENV/GFP plasmids were harvested by trypsinization at 24, 
48, and 72 h pt and re-suspended in fresh media at 4 °C. The GFP mean fluorescent intensity 
(MFI) measured at 488 nm in each cell was analyzed by FACSCanto flow cytometer using 
FACSDiva software version 2.4 (BD Bioscience, USA). The cells harvested on day 7 pt 
were also analyzed for viral NS1 protein by Western blot. Briefly, the cells were lysed in m-
RIPA buffer (150 mM NaCl, 50 mM Tris–HCl, pH 7.4, 1% NP-40, 50 mM EDTA and 
aprotinin) (Sigma, USA). Cell lysates were subjected to 10% SDS-PAGE, and proteins were 
transferred to nitrocellulose membranes and immunoblotted with 1:100 dilution of 
monoclonal antibody against dengue anti-NS1, Clone IPF5SC(2G6) (Puttikhunt et al., 
2003), and 1:5000 secondary antibody conjugated to horseradish peroxidase (Abcam, USA). 
The protein bands were detected by chemiluminescence (Amersham, USA) on the ECL 
film.
2.6. Analysis of virion production
Supernatants of the transfected cells collected on days 1, 4, 6 and 8 pt were determined for 
infectious viral titer by standard plaque titration assay as previously described 
(Leardkamolkarn et al., 2010). Briefly, 200 µl of serially diluted supernatant was inoculated 
onto the confluent monolayer of BHK-21 cells. Then 4 ml of 1st agarose overlay medium 
was applied. The cultures were incubated at 37 °C, in 5% CO2 condition for 7 days, and 2 
ml of 2nd overlay medium with 1% Neutral Red (Sigma, USA) was applied on top. Plaque 
formation was observed during the next few days. Viral titers were calculated as follows:
Titer (PFU/ml) = numbers of plaques × sDF × iDF, where PFU is plaque formation unit, 
sDF is the serial dilution factor; iDF is infection dilution factor (1 ml/0.2 ml = 5). 
Detection limit was 5 PFU/ml.
2.7. Analysis of intracellular replicon RNA in transfected cells
One million BHK-21 cells transfected with 8 µg of each Δ-DENV/GFP plasmid were 
harvested at 24, 48, and 72 h pt, and total intracellular RNA was extracted using the RNeasy 
kit (Qiagen, USA). Residual DNA was removed using RNase-Free DNase kit (Qiagen, 
USA). For FL-DENV/GFP RNA transfected cells, intracellular RNA was extracted from the 
transfected cells on days 4, 6, and 8 pt. First strand cDNA was synthesized using a 
RevertAid™M-MuLV Reverse Transcriptase (Fermentas, Canada) with 1 µl (2% of the total 
extracted RNA) and specific anti-sense primer binding to the 3′NCR (nt 10680–10700; 
5′CATTCCATTTTCTGGCGTTCT3′). Real-time PCR was performed using SYBR Green I 
in the Bio-Rad iQ5 instrument and specific sense primer (nt 10549–10572; 
5′AAGGTGAGATGAAGCTGTAGTCTC3′) and anti-sense primer (nt 10680-10700; 
5′CATTCCATTTTGGCGTTCT3′). Briefly, sample was added in a 25 µl reaction mixture 
containing 1 µl (out of 20 µl RT reaction) of the cDNA, 2.5 µl of 10× High Fidelity Reaction 
buffer, 0.2 µl of 25 µM dNTPs, 1.25 µl of 10 µM of each primer, 0.75 µl of SYBR Green I 
stock solution (1:1000), 0.2 µl of High Fidelity PCR enzyme mix (Fermentas, Canada). The 
thermocycler profile consisted of 3 min of Taq DNA polymerase activation at 94 °C, 
followed by 45 cycles of PCR at 95 °C for 30 s, 55 °C for 30 s and 72 °C for 1 min. To 
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verify the specificity of the amplified product, melting curve analysis was performed. The 
results were analyzed by BioRad iQ5 standard software version 2.0. A standard curve was 
established in every experiment using 10-fold serial diluted standards between 1.16 and 1.16 
× 1010 copies of DENV-16681 infectious clone plasmid, pD2/IC-30P-A. The RNA copy 
numbers were calculated according to the standard curve generated in the real-time PCR for 
comparison. The total RNA copy number = the copy number per reaction × 20 (1/20 of the 
RT sample used in PCR) × 50 (2% of total RNA used in RT).
2.8. Construction and characterization of DENV-2 5′NCR mutants using FL-DENV/GFP and 
Δ-DENV/GFP replicons
Full-length DENV-2 cDNA plasmids containing various mutations in the 5′NCR (Table 1) 
were made previously (Sirigulpanit et al., 2007; Leardkamolkarn et al., 2010). A cDNA 
fragment with A69T substitution isolated from full-length DENV-2.5′-69M plasmid was 
cloned into the FL-DENV/GFP plasmid to replace the corresponding wt fragment. In vitro 
transcribed RNA derived from the resulting FL-DENV-2.5′-69M/GFP plasmid was 
transfected into BHK-21 cells as described above.
cDNA fragments from other full-length infectious cDNA 5′ NCR-mutant clones, 
DENV-2.5′-14M, DENV-2.5′-15M, DENV-2.5′-55M, DENV-2.5′-57M, DENV-2.5′-60M, 
DENV-2.5′-D57M, and DENV-2.5′-D5758M were also cloned into the corresponding 
region of the 4 types of subgenomic Δ-DENV/GFP constructs described above and the 
resulting 28 plasmids were each transfected into BHK-21 cells as described above.
The methods described above were used to evaluate GFP expression, viral RNA 
quantification, and viral NS1 expression of the mutant transfected cells. The DENV-2.5′-
D57M and DENV-2.5′D5758M deletion mutants were included as negative control 
constructs, since our previous results demonstrated that these deletions were totally lethal for 
DENV-2 (Sirigulpanit et al., 2007).
2.9. Statistical analysis
The MFI and RNA copies analysis experiments were performed independently in triplicates. 
The MFI results were analyzed using a one-way ANOVA, followed by a Tukey’s post hoc 
test. The RNA copies were compared by a two-tailed, unpaired, and unequal variant 
Student’s t-test. The differences were considered significant between groups at P < 0.05.
3. Results
3.1. Characterization of the RNA-launched FL-DENV/GFP constructs
In vitro transcribed recombinant RNA from the wt FL-DENV/GFP or FL-
DENV-2.5′-69M/GFP mutant (sometimes abbreviated as 5′-69M from this point) was 
transfected into Vero cells. Viral proteins were detected in the cytoplasm of both transfected 
cells at 24 and 48 h pt (Fig. 2A). In addition, GFP expression was detectable in living cells 
directly under an inverted fluorescent microscope. Cells were harvested, fixed, and stained 
with DAPI on day 4, 6 and 8 pt, and the results showed that the GFP expression was 
restricted to the cytoplasm, and morphology of the transfected cells appeared normal (Fig. 
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2B). No significant difference in protein expression was observed between the wt FL-
DENV/GFP and the 5′-69M transfected cells during day 4–8 pt.
Release of infectious virus from the transfected cells was analyzed by plaque assay of the 
culture supernatant collected on days 1, 4, 6 and 8 pt. Unlike the cells transfected with the 
control wt DENV RNA (from pD2/IC-30P-A, without GFP insertion), which produced high 
titers of the infectious DENV-2, culture of the FL-DENV/GFP RNA transfected cells 
yielded undetectable or minimal levels of infectious virus (only one titration experiment 
resulted in 5 PFU/ml, but other repeated experiments showed no detectable virus plaques). 
Attempts to amplify the virus by cell passage of transfected culture supernatant failed to 
demonstrate viable virus, suggesting that the GFP insertion in the RNA genome caused 
significant defect in virus infectivity.
Quantification of the intracellular viral RNA in transfected BHK-21 cells was conducted on 
days 4, 6 and 8. RNA levels in cells transfected with either FL-DENV/GFP or FL-
DENV-2.5′-69M/GFP were 2–3 log10 less than those in cells transfected with replicable D2/
IC-30P-A infectious viral RNA (without GFP) (Fig. 3). The 5′-69M transfected cells 
exhibited substantially lower RNA levels than the FL-DENV/GFP transfected cells at all 
time points tested (P < 0.05).
3.2. Characterization of the DNA-launched Δ-DENV/GFP replicons
The GFP expression in transfected-BHK-21 cells was similar among all the 4 types of the 
subgenomic Δ-DENV/GFP plasmids (ΔC, ΔCprM/M, ΔprM/M and ΔE), and the GFP 
signals were very strong compared to that in the control transfected cells with commercial 
pAcGFP plasmid (Fig. 4A). Unlike the FL-DENV/GFP RNA transfected cells, the GFP 
expressed by the DNA-launched Δ-DENV/GFP plasmids was detected in both cytoplasm 
and cellular nuclei. The numbers of positive GFP cells were similar among the 4 types of Δ-
DENV/GFP at 24 h pt, and continued to increase between 24 and 72 h (Fig. 4A). The mean 
fluorescent intensity (MFI) of each GFP-autofluorescing cell measured by flow cytometry 
(Fig. 4B) was also comparable among all 4 types of Δ-DENV/GFP transfected cells at 24 h 
pt, suggesting that they achieved similar reporter activity early in the cells. However, at 48–
72 h pt both MFI and the numbers of GFP-positive cells from transfection of ΔprM/M- and 
ΔE-DENV/GFP plasmids became significantly higher (P < 0.05) than those from 
transfection of the ΔC- and ΔCprM/M-DENV/GFP plasmids. In addition, DENV-2 NS1 
proteins were detectable by Western blot in all 4 types of Δ-DEN/GFP transfected cells at 
least up to day 7 pt (Fig. 4C).
Despite the different types of construct, all the 4 Δ-DENV/GFP plasmid-transfected cells 
showed over 100–1000 fold increase in intracellular replicon RNA between 24 and 72 h pt. 
Intracellular RNA of ΔC and ΔCprM/M transfected cells increased from 5.9–6.0 log10 
copies at 24 h pt to 8.8–9.2 log10 copies, while the increase for ΔprM/M and ΔE transfected 
cells were from 6.5–7.0 log10 copies to 9.4–9.7 log10 copies. Repeated experiments with the 
same amount of plasmid input for transfection resulted in similar RNA levels between ΔC 
and ΔCprM/M transfected cells, and between ΔprM/M and ΔE transfected cells. In general, 
the RNA levels of ΔC and ΔCprM/M transfections were approximately 10-fold lower than 
those of ΔprM/M and ΔE transfection at all 3 time points.
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3.3. DENV-2 5′NCR mutagenesis analysis using DNA launched Δ-DENV/GFP replicons
It is important to investigate the potential utility and accuracy of the Δ-DENV/GFP replicons 
in DENV research. For this purpose, we chose five 5′NCR mutations previously shown to 
have attenuation effects in mouse neurovirulence and 2 deletion mutants that were lethal for 
virus (Sirigulpanit et al., 2007; Leardkamolkarn et al., 2010) to be incorporated in the 
replicons (Table 1), and evaluated whether the mutation effects could be measured using the 
replicon reporter system in vitro. Positive GFP expressions were observed in cells 
transfected with all 4 types of Δ-DENV/GFP replicons containing 5′-55M, 5′-60M, 5′-14M, 
5′-15M, 5′-57M, but the positive cell numbers were less than those of the Δ-DENV/GFP 
replicons with wt 16681 5′NCR at 48 h pt (Fig. 5A). The deletion mutants, 5′-D57M and 
5′D5758M, on the other hand, only had a few cells that were GFP positive (Fig. 5A, panels 
g and h). Among the mutants, 5′-55M generally showed the highest numbers of GFP-
positive cells (Fig. 5A, panel b). Except for samples transfected with deletion mutants (5′-
D57M and 5′-D5758M), the numbers of the GFP positive cells transfected with the other 5 
mutants increased between 24 and 72 h post-transfection (data not shown).
The MFI levels of GFP in cells transfected with the deletion mutants were also very low at 
48 h pt (Fig. 5B). Similar MFI were observed between ΔC and ΔCprM/M replicons, and 
between ΔprM/M and ΔE replicons carrying the same mutation (Fig. 5B). Similar to the 
comparison results among the 4 types of unmutated Δ-DENV/GFP replicons, the MFI levels 
produced from the mutant replicons were generally higher from ΔprM/M and ΔE types than 
those from the other 2 types of replicon. All the mutant replicons with 5′NCR mutation had 
significantly weaker (P < 0.001) MFI than their corresponding replicons containing wt 
5′NCR. Except in the ΔE-DENV/GFP replicon, 5′-55M and 5′-14M mutants generally 
resulted in higher MFI levels than the other 3 substitution mutants within the same type of 
replicon. In the ΔE-DENV/GFP mutant group, the 5′-55M still produced higher MFI than 
the other mutants, but the MFI from 5′-14M mutant was the lowest one among the 5 
substitution mutants.
Production of replicon RNA in transfected BHK-21 cells was evaluated by 2-step RT/real-
time PCR at 48 h pt. RNA levels of the deletion mutants (5′-D57M and 5′-D5758M) were 
under the detectable limit (data not shown), indicating that the initial RNA transcripts 
produced from the deletion mutant plasmids were not self-replicable, and they could be used 
as non-replicable controls for the replicon system. All the non-deletion mutants, on the other 
hand, produced significant amounts of RNA (Fig. 6A). Similar to the MFI results, RNA 
levels were comparable between ΔC and ΔCprM/M replicons, and between ΔprM/M and ΔE 
replicons. In general, the RNA levels of ΔC and ΔCprM/M replicons were approximately 
10-fold lower than that of ΔprM/M and ΔE replicons. Compared to their corresponding 
ΔDENV/GFP replicon containing wt 5′NCR, all of the mutants had significantly less (P < 
0.001) intracellular viral RNA levels, and the 5′-60M produced the least amount of RNA (P 
< 0.0001) at 24, 48, and 72 h pt (showed 48 h pt as a representative, Fig. 6A).
The expression of DENV-2 NS1 protein also varied among different types of replicon (Fig. 
6B). No NS1 protein was detected in cells transfected with any of the 5′-D57M and 5′-
D5758M mutants on day 7 pt (data not shown). Among all of the non-deletion mutants, 
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similar to the GFP MFI and intracellular RNA results, 5′-60M expressed the least amount of 
the NS1 protein. Interestingly, all mutants made in the ΔE replicon expressed highest 
amount of NS1 protein when compared to other replicons carrying the same mutation, 
suggesting it may be the optimal type of the Δ-DENV/GFP replicon. Infection of fresh cells 
with supernatant of transfected cells and plaque titration assay confirmed that no infectious 
virus was produced by any of the cells transfected with these subgenomic replicons.
4. Discussion
Successful construction of a full length DENV-2 cDNA clone expressing GFP was 
demonstrated in this study by direct insertion of GFP gene within the signal sequence, which 
is a hydrophobic domain located at the C-terminus of C and upstream of the N-terminus of 
prM (Lindenbach and Rice, 2003). The viral proteins and GFP expression were 
demonstrated in the cytoplasm of the FL-DENV/GFP RNA transfected BHK-21 cells. Since 
GFP gene was incorporated in monocistronic manner, the expression of GFP reporter can be 
used to indicate the viral RNA replication and protein translation efficiency of the 
recombinant plasmid. The FL-DENV/GFP RNA transfected cells failed to generate 
infectious DENV-2, and that was likely due to the insertion of GFP in the signal sequence. 
The GFP insertion at the fifth amino acid of the signal sequence, a 14-amino acid peptide in 
front of the DENV-2 prM, may impair the specific dynamic requirement for the correct 
cleavages of C and prM (Amberg et al., 1994; Amberg and Rice, 1999; Stocks and Lobigs, 
1998; Lobigs and Lee, 2004). The signal sequence is critical for proper translocation of the 
prM into ER lumen during polyprotein processing. Results of the intracellular RNA also 
indicated that no second round of virus infection occurred in cells transfected with FL-
DENV/GFP RNA. Their RNA levels were over 100-fold less than the cells transfected with 
infectious wt DENV-2 RNA on day 4–8 pt when new rounds of DENV-2 infection should 
have already happened. GFP reporter gene has been inserted between E and NS1 gene of a 
full-length YFV cDNA, resulting in recombinant YFV expressing GFP (Bonaldo et al., 
2007). Pierson et al. (2005) also reported a recombinant infectious WNV expressing the 
GFP reporter that was cloned with an internal ribosome entry site (IRES) gene after the stop 
codon of the WNV polyprotein. However, GFP gene in this bicistronic WNV construct 
trended to be deleted after several replication cycles. Recently, construction of WNV was 
made successful by insertion of GFP in the capsid sequences, with some modification, 
resulting in viable virus that benefits to study infectivity, dissemination and transmission of 
the virus in mosquito vector as well as viral tracking in mice (McGee et al., 2010). Although 
our FL-DEN/GFP construct did not yield infectious virus, our main goal for this study was 
to generate a replicon system with reporter GFP to facilitate DENV-2 research. In our 
system, the GFP expression level would reflect the efficiency of initial viral polyprotein 
translation and the viral RNA self-replication within the single-round of the transfected 
cells. Previously, we have shown the 5′-69 mutation of DENV-2 virus is partially attenuated 
for neurovirulence in newborn mice (Sirigulpanit et al., 2007). This A69U substitution was 
conserved among the wt DENV-2 strains of the American genotype causing dengue fever, 
but not dengue hemorrhagic fever, in humans (Leitmeyer et al., 1999). It is located at the 
leading end of the first stem situated at the base of the predicted SLA structure at the 5′-end 
of the genome. The SLA is recognized by viral RNA polymerase (NS5) and participates in 
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cyclization of the viral genome through the interaction with the 3′-end sequence, thereby 
promoting minus-strand viral RNA synthesis (Filomatori et al., 2006). Using the single-
round FL-DENV/GFP RNA-launched system, we confirmed that the 5′-69M construct 
resulted in significantly less (P < 0.05) intracellular viral RNA levels than the FL-
DENV/GFP containing wt 5′NCR construct (Fig. 3).
In addition, we have successfully developed 4 types of subgenomic DENV-2/GFP DNA-
launched-replicons. The deleted DENV-2 structural protein in the subgenomic plasmid was 
replaced by the GFP reporter gene with a FMDV-2A cleavage site to ensure C terminal 
cleavage of GFP (Varnavski et al., 2000). A human cytomegalovirus immediate early (CMV 
IE) promoter was applied upstream of the 5′NCR of DENV genome to initiate RNA 
transcription in the transfected cells (Akrigg et al., 1985; Varnavski et al., 2000). As in the 
FL-DENV/GFP construct, the AcGFP with optimized human codons was chosen as the 
reporter to enhance the GFP expression (Haas et al., 1996). To ensure the Δ-DENV/GFP 
replicons were capable of RNA self-replication, we included all DENV-2 genome parts 
essential for viral RNA-dependent RNA replication with deletion in the structural gene. For 
ΔC construct, most of the C gene except for the first 25 residues containing the cyclization 
motif for NS5 dependent RNA replication (Lo et al., 2003b; You and Padmanabhan, 1999) 
and the last 8 residues containing the signalase site was deleted (Chambers et al., 1990). In 
the ΔCprM/M, the cyclization motif of C and the last 5 residues of the M protein containing 
a signalase cleavage site (Chambers et al., 1990), were retained. In ΔprM/M and ΔE 
constructs, majority parts of the prM/M or E gene, except the N and C-terminal regions, 
were removed. These designs ensured correct protein processing of all NS proteins that are 
largely involved in viral replication, as well as intact 5′ and 3′NCRs of the DENV-2 
genome, thereby retaining essential structures/elements for initial viral protein translation 
and viral RNA replication. Successful establishment of subgenomic flavivirus replicons 
including WNV, YFV and DENV-2 have been demonstrated (Shi et al., 2002; Jones et al., 
2005; Ng et al., 2007), but most of them are RNA-launched system. DNA-launched 
subgenomic DENV-2 replicons based on NGC strain has been achieved before (Pang et al., 
2001), but it did not include any reporter gene.
The GFP signals expressed by our constructs were readily detectable at 24 h pt, increased 
significantly within 24–72 h pt, and lasted stably for 9 days (data not shown). We were also 
able to detect NS1 at 7 days pt. The exponential increase of the RNA levels, the increase of 
positive GFP cells, and the prolonged expression of GFP and NS1, suggested that the 
subgenomic RNAs transcribed from the plasmid inside of the transfected cells were capable 
of protein translation, and self-replication through RNA-dependent RNA replication. The 
non-replicable control constructs; 5′-D57M and 5′-D5758M (deletion mutants), generated 
only minimal GFP and undetectable viral RNA levels (Figs. 5A and 6A). These results 
further demonstrated that all 4 types of the wt DNA-launched Δ-DENV-2/GFP replicons 
were able to generate self-replicative RNA in cells.
Unlike the FL-DENV/GFP RNA-launched construct expressing GFP only in cytoplasm, the 
GFP was observed in both cytoplasm and nuclei in cells transfected with the Δ-DENV/GFP 
DNA-launched constructs. It is not surprising that GFP signal was only observed in the 
cytoplasm of the FL-DENV/GFP RNA transfected cells, because it was fused with the 
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hydrophobic signal sequence and likely was anchored in membranes of the cellular 
compartments (e.g. ER) (Fig. 7A). On the other hand, a FMDV-2A cleavage site was 
included at the C-terminal end of the GFP in all of the Δ-DENV/GFP constructs, resulting in 
small GFP fusion proteins (fused with only partial structural proteins) without any 
transmembrane domain to block its diffusion into nuclei (Fig. 7B). Because of its small size, 
GFP (239 amino acids) can penetrate into nuclei (Hanson and Kohler, 2001).
When comparing the 4 types of the Δ-DENV/GFP replicons, the MFI levels of GFP and the 
replicon RNA were higher from cells transfected with ΔprM/M and ΔE than those with ΔC 
and ΔCprM/M, suggesting that some area within the deleted C gene of ΔC and ΔCprM/M 
replicons may still be involved in up-regulation of the viral RNA replication. This 
observation agrees with earlier reports (Mandl, 2004; Zhu et al., 2007) demonstrating that 
replicons with partial C deletion had adverse effect in flavivirus RNA replication. However, 
as depicted in Fig. 7B, the GFP expressed by ΔC or ΔCprM/M is expected to be translocated 
in cytoplasm, while the GFP expressed by ΔprM/M and ΔE would be in ER lumen. 
Therefore, it is also possible that efficiency of the viral polyprotein processing was affected 
by the alternate GFP sites, and consequently resulted in various efficiencies in RNA 
replication and GFP expression. Nevertheless, despite the different initial translocation sites 
of the GFP expressed by the various subgenomic replicons, we observed similar diffuse 
patterns of GFP signal throughout the cytosol and nuclei among all 4 types of the 
subgenomic replicontransfected cells (Fig. 4A). Although the GFP expressed by ΔprM/M 
and ΔE could be located in the ER lumen during polyprotein processing (Fig. 7B), without 
fusing with any signal sequence or transmembrane peptide, it could not secrete out of the 
cells through the ER-Golgi pathway (Laukkanen et al., 1996). Instead, the soluble GFP in 
the ER cleaved from the FMDV-2A site was capable of translocation across the ER 
membrane to the cytosol (Thomas et al., 2001; Tanudji et al., 2002) and further diffusing 
into nuclei.
Using the Δ-DENV/GFP replicons, we were able to dissect the mutation effects of seven 
5′NCR mutations that we have previously analyzed using the infectious clone system 
(Leardkamolkarn et al., 2010; Sirigulpanit et al., 2007). Our results suggested that deletion 
of nt 57 or 57–58 severely diminished the GFP expression and RNA replication. It is very 
likely that essential RNA structure required for DENV RNA replication was severely 
destroyed with the deletions. All the 5 non-deletion mutants had less GFP intensity and 
RNA levels than the wt in all 4 types of replicons at 48 h pt. With few exceptions, results of 
the same mutation among different types of replicon were generally consistent and in most 
cases their GFP intensity correlated very well with RNA levels. For example, the 5′-55M 
expressing the strongest intensity of GFP had the highest RNA numbers among all the non-
deletion mutants in all 4 types of replicon. The 5′-60M expressing GFP at much lower 
intensity than others also had least amount of RNA levels. Therefore, the GFP intensity 
expressed by these replicon systems can be used as a fast indicator to determine the RNA 
replication efficiency.
Previous studies using infectious clone demonstrated that each of the five 5′NCR 
substitutions caused partial attenuation of mouse neurovirulence (Leardkamolkarn et al., 
2010; Sirigulpanit et al., 2007). Since the replicon systems reported here were measuring 
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events within a single-round transfection, we further demonstrated that the attenuation effect 
of these 5′NCR mutations was due to less RNA replication efficiency. GFP expression 
intensity provided clear evidence of replication defects by the mutations when compared 
them to the wt replicons. Most interestingly, we have observed that different subgenomic 
constructs resulted in different levels of RNA self-replication and GFP expression, and 
constructs with deletions outside of C were generally better than the constructs with partial 
C deletion. Using both the FL-DENV/GFP and Δ-DENV/GFP constructs reported in this 
study, we have demonstrated that these reporter systems can provide a fast and powerful 
platform to study critical molecular determinants involved in viral protein translation and 
viral RNA replication. For example, mutant replicons with mutations at suspected molecular 
determinants can be first screened quickly by comparing their GFP intensity within 24–48 h 
pt. Mutations producing significantly lower GFP intensity can then be selected for further 
study using other platforms, such as the infectious clone system that is much more time and 
labor consuming. In addition, the single-round replication system can complement studies 
using whole replicable viruses. The multiple replicon constructs can also be very useful for 
screening antiviral molecules that target different stages of virus replication. In fact, we and 
others recently have successfully established cells lines that stably express subgenomic 
DENV-2 replicons with GFP tagging (Leardkamolkarn and Sirigulpanit, 2011; Massé et al., 
2010), and both systems have provided a rapid and efficient cell-based fluorescent assay for 
anti-DENV compounds screening.
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Genetic maps of DENV-2, FL-DENV/GFP and Δ-DENV/GFP clones (A) Original wt full-
length DENV-2 16681 cDNA plasmid, pD2/IC-30P-A (Kinney et al., 1997). (B) Full-length 
DENV-2 16681 cDNA with GFP insertion. (C)–(F) 4 types of subgenomic Δ-DENV/GFP 
constructs. T7: T7 promoter, CMV: cytomegalovirus IE promoter. SS: signal sequences for 
prM at C-terminal of C gene (between C and prM). GFP: green fluorescent protein. 
FMDV-2A: foot-and-mouth disease virus 2A protease. Color blocks without any label 
indicated partial deletion or disruption.
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Fluorescent images of cells transfected with the FL-DENV/GFP RNA or FL-
DENV-2.5′-69M/GFP RNA. (A) IFA images showing expression of viral protein in 
transfected cells at 24 and 48 h pt. Green cells (arrows) indicate positive cells, and red cells 
represent negative cells counter stained with Evans blue. (B) Green fluorescence emitted by 
GFP in the transfected cells on days 4, 6 and 8 pt. The cells were nuclear stained with DAPI 
(blue color). The micrographs were taken at 400× magnification. (For interpretation of the 
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references to color in this figure legend, the reader is referred to the web version of the 
article.)
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Intracellular viral RNA copy numbers in wt DENV, FL-DENV/GFP and FL-
DENV-2.5′-69M/GFP RNA transfected BHK-21 cells on days 4, 6 and 8 pt.
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(A) GFP expression of the ΔC-DENV/GFP, ΔCprM/M-DENV/GFP, ΔprM-DENV/GFP, 
ΔE-DENV/GFP, or the control AcGFP plasmid in BHK-21 cells at 24, 48 and 72 h pt. (B) 
MFI of GFP in Δ-DENV/GFP transfected BHK-21 cells at 24, 48 and 72 h pt. (C) Western 
blot analysis of DENV-2 NS1 protein in plasmid-transfected BHK-21 cells on day 7 pt. (a) 
wt DEN-2 16681 plasmid (pD2/IC-30P-A), and (b) ΔCprM/M-, (c) ΔprM/M-, (d) ΔC-, and 
(e) ΔE-DENV/GFP plasmids.
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(A) Fluorescent images of Δ-DENV/GFP plasmid-transfected cells at 48 h pt. Δ-DENV/GFP 
replicons with (a) wt 5′NCR, (b) DENV-2.5′-55 M, (c) DENV-2.5′-60M, (d) 
DENV-2.5′-14M, (e) DENV-2.5′-15M, (f) DENV-2.5′-57M, (g) DENV-2.5′-D57M, and (h) 
DENV-2.5′-5758M. (B) MFI of GFP in BHK-21 cells transfected with Δ-DENV/GFP 
plasmids at 48 h pt. MFI in mutant-transfected cells were all significantly less (P < 0.001) 
than those in cells transfected with corresponding replicon containing wt 5′NCR.
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(A) Intracellular replicon RNA copy numbers of cells transfected with Δ-DENV/GFP 
plasmids at 48 h pt. *P < 0.001; **P < 0.0001(B) DENV-2 NS1 protein (Western blot) in 
BHK-21 cells transfected with Δ-DENV/GFP plasmids at day 7 pt.
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Predicted locations and protein processing of GFP within DENV-2 polyprotein. (A) FL-
DENV/GFP and (B) Δ-DENV/GFP replicons.
Leardkamolkarn et al. Page 22

























Leardkamolkarn et al. Page 23
Table 1
Wild-type (wt) and 5′NCR mutations.
Name Mutation
nt position Substitution
DENV-2 16681 None (wt)
DENV-2.5′-69M 69 A → T
DENV-2.5′-14M 14 C → A
DENV-2.5′-15M 15 G → T
DENV-2.5′-55M 55 A → G
DENV-2.5′-57M 57 C → T
DENV-2.5′-60M 60 A → G
DENV-2.5′-D57 57 Deletion
DENV-2.5′-D5758 57 and 58 Deletion
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